Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,138.00    28.00 (2.52%)
Bid:
1,138.00
Ask:
1,146.00
Spread: 8.00 (0.703%)
Market Cap: £389.62m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Win

28 Apr 2014 07:00

RNS Number : 6008F
Craneware plc
28 April 2014
 

 Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

28 April 2014 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, is pleased to announce the signing of a significant multi-year contract with a large multi-system hospital group in the US. The contract is expected to deliver $3.8m revenue to the Group during the seven year term. The Company's revenue recognition policy means that whilst initial implementation is scheduled in the current financial year, the full impact of the revenue will be seen from FY15 onwards.

 

The hospital system manages in excess of $1.5 billion operating expenses, across multiple US states. The contract is for the implementation of Chargemaster Corporate Toolkit® and related products within Craneware's Revenue Cycle product family. One of the key aspects of the corporate version of Chargemaster Toolkit is the ability to establish and manage a corporate standard chargemaster file across multiple hospitals and enable system-wide reporting. The products will be used to reduce billing errors, ensure the timely and accurate submission of claims and manage compliance risk. This was a competitive win, replacing an incumbent provider.

 

Keith Neilson, CEO of Craneware plc commented, "We are delighted to have secured this competitive win, demonstrating the quality and strength of our offering in the corporate environment with our ability to deliver compelling levels of return on investment for organisations of all sizes across the US healthcare industry."

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Heather Armstrong

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTKMGZDNNLGDZG
Date   Source Headline
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20233:52 pmRNSVesting of Long Term Incentive Plan Awards
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
27th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSFY23 Trading Update and Notice of Results
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20234:44 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.